Data updated: Mar 10, 2026
TELMISARTAN AND HYDROCHLOROTHIAZIDE
HYDROCHLOROTHIAZIDE
Approved 2014-02-25
8
Indications
--
Phase 3 Trials
12
Years on Market
Details
- Status
- Discontinued
- First Approved
- 2014-02-25
- Routes
- ORAL
- Dosage Forms
- TABLET
TELMISARTAN AND HYDROCHLOROTHIAZIDE Approval History
Loading approval history...
What TELMISARTAN AND HYDROCHLOROTHIAZIDE Treats
8 FDA approvalsOriginally approved for its first indication in 2014 . Covers 8 distinct patient populations.
- Other (8)
Other
(8 approvals)- • Approved indication (Feb 2014)Letter
- • Approved indication (Aug 2014)
- • Approved indication (Nov 2015)
- • Approved indication (Dec 2016)
- • Approved indication (Aug 2017)
- • Approved indication (Nov 2017)
- • Approved indication (Mar 2019)
- • Approved indication (Mar 2025)
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
TELMISARTAN AND HYDROCHLOROTHIAZIDE FDA Label Details
ProWant competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.